Telemedicine, Medication Abortion, and Access After Roe v. Wade
- PMID: 35830673
- PMCID: PMC9342806
- DOI: 10.2105/AJPH.2022.306948
Telemedicine, Medication Abortion, and Access After Roe v. Wade
Comment on
-
Potential Impact of Telemedicine for Medication Abortion Policy and Programming Changes on Abortion Accessibility in the United States.Am J Public Health. 2022 Aug;112(8):1202-1211. doi: 10.2105/AJPH.2022.306876. Am J Public Health. 2022. PMID: 35830676 Free PMC article.
References
-
- Jones RK, Nash E, Cross L, Philben J, Kirstein M.2022. https://www.guttmacher.org/article/2022/02/medication-abortion-now-accou...
-
- American College of Obstetricians and Gynecologists. 2018. https://www.acog.org/clinical-information/policy-and-position-statements...
-
- Razon N, Wulf S, Perez C, et al. Exploring the impact of mifepristone’s risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics. Contraception. 2022;109:19–24. doi: 10.1016/j.contraception.2022.01.017. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
